United States · Series A startup

Who invested in Virtudent

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $8.0MJul 2018
Investors
5
See who backed them

The rounds

  1. Jul 2018
    Series A$8.0M

    Reported by FinSMEsSEC filing: $8.0M sold, first sale Jun 2018

Founders and team

From the SEC filings it signed: 2 on the team.

  • Hitesh TolaniExecutive Officer, Director, Promoteri
  • John VoithExecutive Officeri

On the board, as filediServjeet Bhachu

Everyone who backed them

MassChallengeAccelerator1round
406 VenturesVC firm1round
406 Ventures/ SpringRockno record of our own yet1round
Desh Deshpandeno record of our own yet1round
The Sparta Groupno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Virtudent

Who invested in Virtudent?

Virtudent's investors include MassChallenge, 406 Ventures, 406 Ventures/ SpringRock, Desh Deshpande and The Sparta Group.

How much has Virtudent raised?

Virtudent has raised $8.0M across 1 round since 2018.

When did Virtudent last raise?

Virtudent's most recent round was a Series A of $8.0M in Jul 2018.

What was Virtudent's biggest round?

Its most recent round, $8.0M in Jul 2018, is also its largest on record.

Who backed Virtudent first?

Virtudent's first round on record, in Jul 2018, was backed by MassChallenge, 406 Ventures and 406 Ventures/ SpringRock and 2 others.

What stage is Virtudent at?

Virtudent's latest named round is a Series A, in Jul 2018.

Where is Virtudent based?

Virtudent is based in the United States.

Companies like Virtudent

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.